← Psychiatry course path Level 8 · Cumulative level test Cumulative level test: From lived experience to service systems: how psychiatric knowledge is made, measured and contested Check understanding, separately from reading 12 questions · 80% to pass · no timer. This longer test revisits both units in the level. These authored questions assess recognition and application of the taught distinctions, not professional qualification. You may review the lessons and retry. Repeat attempts reuse the question bank; a remembered answer is not proof of transfer to a new situation.
Saving a lesson records reading only. Previous lesson completions have not been converted into passing scores. You can continue reading without a pass; the assessment remains unpassed.
Question 1
A fictional research team reports that a five-item experience scale has internal consistency of 0.91, test-retest reliability of 0.85, and a factor structure matching its published form. Their paper proposes the scale as a clinical screening tool for a specific perceptual anomaly. Using this level's treatment of description, instruments and measurement, what has the team established and what has it not? It has established consistency and structure: the items hang together, the scores repeat when nothing has changed, and the scale behaves like a one-dimensional measure, but not that the scale codes the anomaly as described, not that its scores behave equivalently across the groups it would be used with, and not what a score or a change in it means. It has established that the scale measures the anomaly, since a high internal consistency combined with a stable factor structure and reliable retest scores is the standard evidence that a scale is unidimensional and therefore specific to the construct it was designed for.Question 6
A fictional formulary paper concludes: 'Certainty of evidence is low for this outcome, so the intervention does not work for it.' Which reformulation is correct, and what should the certainty rating have been doing? Low certainty is equivalent to no recommendation at all, so a formulary committee should defer the decision until certainty rises to moderate or high rather than reasoning about a low-certainty estimate. Low certainty means the estimate could easily be different; it may be compatible with a worthwhile benefit, with no effect, or with harm, and the rating should record which named factors were rated down (risk of bias, inconsistency, indirectness, imprecision, publication bias) so that a decision can weigh the plausible range rather than a verdict.Question 11
A fictional clinician reads two reports of the same person's experience. The first records: 'Patient reports that thoughts are inserted; no insight.' The second records: 'Says thoughts arrive already spoken, in a voice that is not his, though he says they come from his own head; when asked whether that makes the thoughts his, says he does not know what would make a thought his.' Using this level's material, assess the two records and what each can support. The second preserves the person's words, separates the description from any judgement, and adds a distinction the first has hidden, the experience is estranged in its mode while its spatial origin remains his own, and his uncertainty concerns ownership rather than the fact of the experience, so it supports clinical reasoning about the form of the experience while the first supports only a conclusion, and neither supports a diagnosis. The first is the better clinical record because it is concise and uses standard terminology, which allows another clinician to reproduce the same assessment; the second is idiosyncratic and risks being misinterpreted by a reader who does not know the person.Question 12
Assemble the reasoning for this decision: a fictional service with 4,000 people on its caseload wants to commission a new intensive intervention based on one positive randomised trial conducted in a different country, and the trial's own service had one trained clinician per 40 patients while this service has one per 120. Write the four-part assessment and the single cheapest measurement that would most reduce the uncertainty. The cheapest and most decisive step is to survey the caseload about their willingness to try the new intervention, since adoption is only worthwhile if the people concerned are willing to participate and satisfaction is the outcome most relevant to them. One: the evidence is a single trial, so provenance and pre-specification should be checked before the effect size is used at all. Two: the comparator and outcome definitions must match the local alternative, or the estimate will not transfer. Three: staffing is part of the intervention, one clinician per 40 versus one per 120 is a different treatment, so fidelity, caseload and supervision will determine whether the effect is even available here. Four: capacity and displacement decide reach: with limited capacity the intervention can serve a fraction of the caseload and will displace whatever currently fills those clinician hours. The cheapest uncertainty-reducing measurement is the service's own current outcome and contact data by clinician, which establishes the local baseline and shows how much clinician-level variance exists, allowing the trial effect to be read against local delivery conditions.Score this attempt
→ Next level: A cross-section is not a population: prevalence, incidence and who is missing from the snapshot Continuing does not mark this assessment passed.
Progress stays in this browser, on this device, not an account or cloud backup. Clearing browser data removes it. Visits never count as study. Previous untimed legacy completions are not invented as study days.